These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17467904)

  • 1. Oxycodone and morphine have distinctly different pharmacological profiles: radioligand binding and behavioural studies in two rat models of neuropathic pain.
    Nielsen CK; Ross FB; Lotfipour S; Saini KS; Edwards SR; Smith MT
    Pain; 2007 Dec; 132(3):289-300. PubMed ID: 17467904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated.
    Ross FB; Smith MT
    Pain; 1997 Nov; 73(2):151-157. PubMed ID: 9415500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action.
    Horan PJ; Wild KD; Kazmierski WM; Ferguson R; Hruby VJ; Weber SJ; Davis TP; Fang L; Knapp RJ; Yamamura HI
    Eur J Pharmacol; 1993 Mar; 233(1):53-62. PubMed ID: 8386089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats.
    Lemberg KK; Kontinen VK; Siiskonen AO; Viljakka KM; Yli-Kauhaluoma JT; Korpi ER; Kalso EA
    Anesthesiology; 2006 Oct; 105(4):801-12. PubMed ID: 17006080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
    Sterious SN; Walker EA
    J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat.
    Lemberg K; Kontinen VK; Viljakka K; Kylänlahti I; Yli-Kauhaluoma J; Kalso E
    Anesth Analg; 2006 Jun; 102(6):1768-74. PubMed ID: 16717324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-administration of sub-antinociceptive doses of oxycodone and morphine produces marked antinociceptive synergy with reduced CNS side-effects in rats.
    Ross FB; Wallis SC; Smith MT
    Pain; 2000 Feb; 84(2-3):421-8. PubMed ID: 10666549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacological profiles of morphine and oxycodone under a neuropathic pain-like state in mice: evidence for less sensitivity to morphine.
    Narita M; Nakamura A; Ozaki M; Imai S; Miyoshi K; Suzuki M; Suzuki T
    Neuropsychopharmacology; 2008 Apr; 33(5):1097-112. PubMed ID: 17593930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive effect of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Tamura N; Kamei J
    Eur J Pharmacol; 2005 Nov; 524(1-3):75-9. PubMed ID: 16256106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
    Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
    Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G protein-gated inwardly rectifying potassium (KIR3) channels play a primary role in the antinociceptive effect of oxycodone, but not morphine, at supraspinal sites.
    Nakamura A; Fujita M; Ono H; Hongo Y; Kanbara T; Ogawa K; Morioka Y; Nishiyori A; Shibasaki M; Mori T; Suzuki T; Sakaguchi G; Kato A; Hasegawa M
    Br J Pharmacol; 2014 Jan; 171(1):253-64. PubMed ID: 24117458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral pharmacology of the mixed-action delta-selective opioid receptor agonist BBI-11008: studies on acute, inflammatory and neuropathic pain, respiration, and drug self-administration.
    Stevenson GW; Giuvelis D; Cormier J; Cone K; Atherton P; Krivitsky R; Warner E; St Laurent B; Dutra J; Bidlack JM; Szabò L; Polt R; Bilsky EJ
    Psychopharmacology (Berl); 2020 Apr; 237(4):1195-1208. PubMed ID: 31912192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
    Chieng B; Connor M; Christie MJ
    Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
    Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
    Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incomplete, asymmetric, and route-dependent cross-tolerance between oxycodone and morphine in the Dark Agouti rat.
    Nielsen CK; Ross FB; Smith MT
    J Pharmacol Exp Ther; 2000 Oct; 295(1):91-9. PubMed ID: 10991965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
    Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
    Gouardères C; Jhamandas K; Sutak M; Zajac JM
    Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
    Lohmann AB; Welch SP
    Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats.
    Steinmiller CL; Young AM
    Psychopharmacology (Berl); 2008 Jan; 195(4):497-507. PubMed ID: 17882404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.